assessed in Atherosclerosis, Kuremoto K., Watanabe Y., Ohmura H., Shimada K., Mokuno Daida H.. R/R genotype of human paraoxonase (PON) is protective against lipoprotein oxidation and coronary artery disease in Japanese subjects. J. Atheroscler. Thromb., Leviev H., Poirier O., Nicaud V., Evans A., Kee F.. Arveile, Morrison C., Cambien F., James R.W.. High paraxonase PON gene promoter polymorphisms are associated with a reduced risk of vascular disease in younger coronary patients. Atherosclerosis, Mackness M.I.. Arrol S.. Abbott C.A.. Durrington P.N. Lipoprotein-associated paraoxonase. Atherosclerosis, Mackness M.I.. Arrol S.. Mackness B.. Durrington P.N.. Alloenzymes of paraoxonase and the effectiveness of lipoproteins in protecting low-density lipoprotein against peroxidation. Lancet, Mackness B., Mackness M.I., Arrol S., Turkie W., Durrington B. Effect of the molecular polymorphisms of human PON on the rate of hydrolysis of paraxon. Br. J. Pharmacol., Mackness B., Mackness M.I., Arrol S., Turkie W., Durrington Effect of the human serum paraoxonase and polymorphisms on the protection by high-density lipoprotein low-density lipoprotein oxidative modification. FEBS Lett., Mackness B., Davies G.K., Turkie W.. Lee E.. Roberts D.H.. Hill Roberts C.. Durrington P.N.. Mackness M.I.. Paraoxonase in coronary heart disease. Atheroscl. Thromb. Vasc. Biol., Mackness B., Durrington P., Meldrum P., Yarnell J., Azam N., Mackness M.. Low paraxonase activity predicts